TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial by Yoshino, Takayuki, Dr, Mizunuma, Nobuyuki, MD, Yamazaki, Kentaro, MD, Nishina, Tomohiro, MD, Komatsu, Yoshito, MD, Baba, Hideo, Prof, Tsuji, Akihito, MD, Yamaguchi, Kensei, MD, Muro, Kei, MD, Sugimoto, Naotoshi, MD, Tsuji, Yasushi, MD, Moriwaki, Toshikazu, MD, Esaki, Taito, MD, Hamada, Chikuma, Prof, Tanase, Takanori, MSc, Ohtsu, Atsushi, MD

Get full text

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial by Grothey, Axel, MD, Cutsem, Eric Van, Prof, Sobrero, Alberto, MD, Siena, Salvatore, MD, Falcone, Alfredo, MD, Ychou, Marc, MD, Humblet, Yves, MD, Bouché, Olivier, MD, Mineur, Laurent, MD, Barone, Carlo, MD, Adenis, Antoine, MD, Tabernero, Josep, MD, Yoshino, Takayuki, MD, Lenz, Heinz-Josef, MD, Goldberg, Richard M, MD, Sargent, Daniel J, PhD, Cihon, Frank, MS, Cupit, Lisa, MD, Wagner, Andrea, MD, Laurent, Dirk, DrMed

Get full text